温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.msd.com/what-we-do
点击访问原文链接

What we do - MSD

进入原网站 导航首页
What we do - MSD Skip to content

Search everything Close Menu Close Main menu Company Who we are What we do Stories History Sustainability Sustainability overview Philanthropy MSD Medical Outreach Program Impact Venture Fund Transparency disclosures Sustainability resources Leadership Leadership overview Board of directors Executive team Culture & values Culture & values overview Code of conduct, ethics and compliance Diversity and inclusion Policies and positions Suppliers Suppliers overview Supplier registration Supplier help for Ariba Research Research overview Areas of focus Oncology Vaccines Infectious diseases Cardiovascular disease Immunology Neuroscience Ophthalmology Areas of innovation Data science and artificial intelligence Green and sustainable science Our therapeutic modalities Translational medicine Pipeline Business development and licensing Clinical Trials Clinical trials overview Diversity in clinical trials R&D locations How we invent Meet our scientists Publications Safety data sheets (SDS) Product patents Patients Patients overview Play an active role in your health care Fighting counterfeit medicine Media Media overview News releases Company statements Company fact sheet Investors Investors overview Events and presentations Stock information Careers Who we are Learn more Contact us What can we help you find? Search for: What we do We use the power of leading-edge science to save and improve lives around the world.

Advancing innovative science to protect and improve health

We’re a global health care company working to deliver innovative health solutions through our medicines, vaccines, biologic therapies and animal health products. We’re focused on discovering new solutions for today and the future.

Research | Sustainability I Partnerships | Manufacturing | Animal Health

Research The journey to discovery is guided by science and inspired by patients. We follow the science where we can make the greatest difference.

Our areas of focus Oncology Vaccines Infectious diseases Cardio-metabolic disorders Immunology Neuroscience Ophthalmology Research
Pipeline × From the lab to patients Moving from molecule to market requires innovation, expertise, tenacity and agility. It includes the work of many people.

The journey of a molecule Creating a medicine or vaccine is a journey — from the lab to patients.

Learn more × Sustainability From finding solutions for some of the world’s most debilitating diseases, to getting our medicines and vaccines to those in need and building more effective health systems, we’re always on a mission to create a better world.

Making an impact We operate responsibly every day to enable a safe and healthy future for people and communities globally.

Learn more
Purpose for Progress Impact Report 2024/2025 × Business development and licensing We build strong partnerships to help translate innovations into therapies. Our collaborations have the potential to impact the lives of millions. 

Building strong partnerships We work with partners, from early-stage science to clinical-stage programs, to deliver new therapies to patients.

Learn more × Manufacturing We’re committed to manufacturing life-changing medicines and vaccines to help people and animals around the world.

Innovating for sustainable supply Our manufacturing network empowers us to meet today’s growing demand while maintaining our unwavering focus on safety and quality.

Learn more × Our animal health business MSD Animal Health is our company’s global animal health business dedicated to preserving and improving the health, well-being and performance of both livestock and companion animals and the people who care for them.

MSD Animal Health MSD Animal Health has a rich history of innovation, commitment to research and entrepreneurship in animal health dating back over 70 years.

Through its commitment to The Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, producers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products.

Visit MSD Animal Health × Learn more about what we do Read our stories

Learn about the heartbeat of our company.

How wearable technology powers patient-focused drug development Our scientists are exploring the use of sensor-based technologies and digital clinical measures to improve disease understanding Our Q4 and full-year 2025 financial results MSD’s Q4 and full-year 2025 sales performance reflects strength across oncology and animal health, as well as increasing contributions from new launches. Our company announced Q4 worldwide sales of $16.4 billion. Full-year 2025 worldwide sales were $65.0 billion. “In 2025, we continued to advance leading-edge science to deliver transformative medicines and vaccines that are improving […] 5 ways we’re transforming artificial intelligence into impact We’re applying AI across our company to help us work smarter and faster so we can reach patients sooner Acting early in cancer detection Diagnosing cancer early, before it has spread, may potentially lead to better outcomes Previous Next Who we are We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.

Learn more

Related links Our culture and values It all comes back to saving and improving lives. Careers

Are you passionate about building a meaningful career? Come work with us!

Patients We're here to help you get the information you need to guide you on your health journey. Connect with us on social For patients and health care professionals MSD Manuals
Medical information source covering thousands of topics in all fields of medicine Clinical trials
Learn about our clinical trials and find available studies Sustainability Impact Report
Reporting on our commitment to operating responsibly to benefit society MSD for Mothers
An initiative to create a world where no woman has to die giving life About MSD MSD Animal Health
The global animal health business unit of MSD Contact Us
If you have a question or need more information about us, find out who you should contact. Forward-looking statementCookie policyCookie PreferencesPrivacyTerms of useAccessibilitySitemap Copyright © 2026 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept

智能索引记录